Región Metropolitana de Santiago
Este organismo compró $35.329.096.472 en 11.633 órdenes de compra , sobre todo en Medicamentos y productos farmacéuticos / Medicamentos anti infecciosos / Medicamentos antivirales y le compró principalmente a Sur Medical SpA.
238 meses con data · color por monto (sqrt scale)
| Año | Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Total año |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
| $1367,1 M |
| 2025 | $2402,7 M |
| 2024 | $2107,2 M |
| 2023 | $2816,8 M |
| 2022 | $1338 M |
| 2021 | $1018,6 M |
| 2020 | $888,8 M |
| 2019 | $901,2 M |
| 2018 | $1471,2 M |
| 2017 | $786,1 M |
| 2016 | $14,2 mil M |
| 2015 | $919,8 M |
| 2014 | $428,8 M |
| 2013 | $340,8 M |
| 2012 | $359,5 M |
| 2011 | $701,4 M |
| 2010 | $913,7 M |
| 2009 | $590,7 M |
| 2008 | $571,8 M |
| 2007 | $1180,7 M |
| 2006 | $34,7 M |
238 períodos con data
Fuente: Agregaciones mensuales sobre OCs ingeridas
10 contrapartes
Fuente: Tabla top_contrapartes_comprador
| Código | Fecha | Proveedor | Estado | Monto |
|---|---|---|---|---|
| 2980-358-SE25 | 15-10-2025 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $56.384 |
| 2980-349-SE25 | 07-10-2025 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $12.906.053 |
| 2980-350-SE25 | 07-10-2025 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $269.947 |
| 2980-347-AG25 | 06-10-2025 | Pfizer Chile S.A. | Recepcion Conforme | $3.519.235 |
| 2980-348-AG25 | 06-10-2025 | Comercializadora de Alimentos Especializados, Medicamentos y Dispositivos Medico | Recepcion Conforme | $342.720 |
| 2980-346-AG25 | 01-10-2025 | Novofarma Service S.A. | Recepcion Conforme | $4.760.095 |
| 2980-339-SE25 | 26-09-2025 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $810.682 |
| 2980-340-SE25 | 26-09-2025 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $338.288 |
| 2980-341-SE25 | 26-09-2025 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $13.782.264 |
| 2980-342-SE25 | 26-09-2025 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $604.337 |
| 2980-343-SE25 | 26-09-2025 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $3.289.718 |
| 2980-344-SE25 | 26-09-2025 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $20.296.234 |
| 2980-338-AG25 | 23-09-2025 | Glaxosmithkline Chile Farmaceutica Limitada | Recepcion Conforme | $544.217 |
| 2980-345-AG25 | 23-09-2025 | Productos Farmoquimicos Roche Limitada | Recepcion Conforme | $2.808.743 |
| 2980-315-AG25 | 22-09-2025 | Astrazeneca S.A. | Recepcion Conforme | $6.129.404 |
| 2980-316-AG25 | 22-09-2025 | Johnson y Johnson de Chile S.A. | Recepcion Conforme | $3.334.951 |
| 2980-317-AG25 | 22-09-2025 | Scienza Chile SpA | Recepcion Conforme | $5.414.500 |
| 2980-318-AG25 | 22-09-2025 | Johnson y Johnson de Chile S.A. | Recepcion Conforme | $5.247.900 |
| 2980-319-AG25 | 22-09-2025 | Bristol Myers Squibb de Chile Agenc de e R Squibb & Sons Interam Corpo | Recepcion Conforme | $3.147.740 |
| 2980-320-AG25 | 22-09-2025 | Abbvie Productos Farmaceuticos Limitada | Recepcion Conforme | $4.748.100 |
| 2980-321-AG25 | 22-09-2025 | Novartis Chile S.A. | Recepcion Conforme | $5.895.474 |
| 2980-322-AG25 | 22-09-2025 | Novartis Chile S.A. | Recepcion Conforme | $4.528.038 |
| 2980-323-AG25 | 22-09-2025 | Novartis Chile S.A. | Recepcion Conforme | $2.942.880 |
| 2980-324-AG25 | 22-09-2025 | Novofarma Service S.A. | Recepcion Conforme | $4.760.095 |
| 2980-325-AG25 | 22-09-2025 | Glaxosmithkline Chile Farmaceutica Limitada | Recepcion Conforme | $4.895.327 |
| 2980-326-AG25 | 22-09-2025 | Synthon Chile Limitada | Recepcion Conforme | $419.832 |
| 2980-327-AG25 | 22-09-2025 | Novofarma Service S.A. | Recepcion Conforme | $6.233.833 |
| 2980-328-AG25 | 22-09-2025 | Novartis Chile S.A. | Recepcion Conforme | $1.854.325 |
| 2980-329-AG25 | 22-09-2025 | Synthon Chile Limitada | Recepcion Conforme | $6.283.200 |
| 2980-330-AG25 | 22-09-2025 | Gador Limitada | Recepcion Conforme | $2.465.870 |
